Over several hours of discussion, members of the Food and Drug Administration (FDA) panel of outside experts voiced frustration that Pfizer had provided little data on safety of extra doses
Read more here:: Post India Listing
Follow Our Network On LinkedIn: Follow link
Search India recent news in rumors and anything online listing
Over several hours of discussion, members of the Food and Drug Administration (FDA) panel of outside experts voiced frustration that Pfizer had provided little data on safety of extra doses
Read more here:: Post India Listing